ANNORA PHARMA FDA Approval ANDA 215761

ANDA 215761

ANNORA PHARMA

FDA Drug Application

Application #215761

Application Sponsors

ANDA 215761ANNORA PHARMA

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL5MG0SOLIFENACIN SUCCINATESOLIFENACIN SUCCINATE
002TABLET;ORAL10MG0SOLIFENACIN SUCCINATESOLIFENACIN SUCCINATE

FDA Submissions

UNKNOWN; ORIG1AP2022-06-15STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215761
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.